|
|
||||
|
Protection for vaccine makers
Email: Lynne Lederman - LynneLederman@yahoo.com News from The Scientist 2003, 4(1):20031027-02
|
||||
|
|
||||
|
Lawsuits are continuing to have a chilling effect on vaccine producers, both reducing the number of companies willing to get into the vaccine business and raising the costs of development, according to legal and industry representatives at the Vaccines meeting held October 22–24 in Arlington, Va. (cosponsored by The Scientist). On the gathering's first day, legislation to limit class-action lawsuits and large damage awards against corporations failed by a single vote in Congress, killing the bill (S 274) for this year and leaving meeting attendees predicting a negative effect on the vaccine industry.
|
|
|||||||||
|
|||||||||
|